Active substance
Sodium citrate
- Health Canada 2
- UK MHRA 2
- NHS prices 3
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| ANTICOAGULANT SOD CITRATE SOLTN 4GM/100ML | 00060313 | 4 G / 100 ML | SOLUTION · EXTRACORPOREAL | BAXTER CORPORATION |
| ANTICOAGULANT SODIUM CITRATE SOLUTION, USP | 02529637 | 4 G / 100 ML | SOLUTION · EXTRACORPOREAL | FRESENIUS KABI CANADA LTD |
UK MHRA United Kingdom — marketing authorisations
| Product | Authorisation | Holder | Legal status |
|---|---|---|---|
| SODIUM CITRATE 0.3M ORAL SOLUTION | PL 01883/0343 | MACARTHYS LABORATORIES LIMITED | POM |
| UROGON CYSTITIS RELIEF 4G GRANULES FOR ORAL SOLUTION | PL 08977/0020 | ASPAR PHARMACEUTICALS LIMITED | POM |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| NHS Drug Tariff | Sodium citrate 441.17mg/5ml oral solution | £4.70 | 30 ml | 1 Oct 2026 |
| NHS Drug Tariff | Sodium citrate 4g granules for oral solution sachets | £3.16 | 6 sachet | 1 Oct 2026 |
| NHS Drug Tariff | Sodium citrate 4g oral powder sachets | £2.31 | 6 sachet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Combinations containing Sodium citrate
- Diphenhydramine + sodium citrate
- Sodium chloride + sodium citrate
- Ammonium chloride + diphenhydramine + sodium citrate
- Diphenhydramine + menthol + sodium citrate
- Ammonium + chlorpheniram maleat + dextromethorphan + sodium citrate
- Citric acid + sodium bicarbonate + sodium citrate + tartaric acid
- Dextrose + potassium chloride + sodium chloride + sodium citrate
- Dextrose + potassium citrate + sodium chloride + sodium citrate
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), MHRA category lists of UK marketing authorisations (Open Government Licence v3.0), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.